
HIMS Stock Forecast & Price Target
HIMS Analyst Ratings
Bulls say
Hims & Hers Health is a rapidly growing telehealth company, with a successful digital platform and strong financial performance. Their focus on long-term retention and efficient marketing strategies have yielded impressive results, with continued investments in technology and global expansion positioning the company for continued success. Despite competition, Hims & Hers has a positive outlook due to its strong business model and proven ability to drive growth.
Bears say
Hims & Hers Health is facing intense competition from both established healthcare giants and venture-backed startups, which could increase marketing and operational expenses, pressure margins, and lead to customer attrition. The company's recent entry into the GLP-1 market also presents unique risks, including potential regulatory challenges and higher operational costs. Despite its expanding treatment portfolio, Hims & Hers must carefully navigate these challenges to achieve its long-term revenue and profitability targets.
This aggregate rating is based on analysts' research of Hims & Hers Health and is not a guaranteed prediction by Public.com or investment advice.
HIMS Analyst Forecast & Price Prediction
Start investing in HIMS
Order type
Buy in
Order amount
Est. shares
0 shares